Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

biote Corp. Director's Dealing 2022

Nov 18, 2022

33946_dirs_2022-11-18_8087ca4a-f86c-4ee5-8d26-f56685dc7740.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2022-11-15

Reporting Person: Cone Stephen Mark (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-15 Stock Option (Right to Buy) $3.97 A 31696 Acquired 2032-11-14 Class A Common Stock (31696) Direct

Footnotes

F1: All shares subject to the option award shall vest on the earlier of May 26, 2023 or the day prior to the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.